
|Videos|January 29, 2018
What Was the Most Notable Orphan Drug Approval in 2017?
Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, discusses the importance of new orphan drug approvals for patients.
Advertisement
Gilbert: Well, it’s interesting because there are many orphan drugs that have been approved and are in the pipeline, but for a patient who has an orphan or rare disease, whichever one is treating their disease is the most notable.
Many of these patients have not had treatment options before. So, the most important one is the one that is treating you, as the patient, or your family member.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
PBM Reform Within 2026 Appropriations Bill Signed Into Law
2
Most Favored Nation Drug Pricing: Analysis and Implications
3
From CAR T to Gene Therapy, Pharmacists Prepare for What’s Next at the 2026 Tandem Meeting
4
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
5


























